Ardal Pharma SRL
Ardal Pharma reported total assets of €1.22m at the end of the 2025 financial year (annual accounts filed with the NBB on 18 Aug 2026).
The score of Ardal Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +28 % Total assets -2 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Ardal Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 18 Aug 2026
- Year ended 31 Dec 2024filed on 25 Aug 2025
- Year ended 31 Dec 2023filed on 28 Jun 2024
- Year ended 31 Dec 2022filed on 02 Jul 2023
- Year ended 31 Dec 2021filed on 12 Jul 2022
Ardal Pharma's financial analysis
- Solvency64.8%sector median: 50.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Ardal Pharma
Ardal Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0843.540.209
- VAT number
- BE0843540209
- Peppol
- Registered · 0208:0843540209 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 09 Feb 2012
- Registered office
- 1090 Jette
- Latest accounts
- 2025 · filed on 18 Aug 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
Ardal Pharma (SRL) has been based in Jette since 2012, active in: business and other management consultancy activities. For 2025, it reports a net profit of 59,589 € and equity of 788,921 €; its revenue is not published. Its solvency stands at 64.8%, above the median of its sector (50.8%).
Companies similar to Ardal Pharma
Companies in the same business, of comparable size and area, outside its group.
- SilvaH Business and other management consultancy activities Kapellen · balance sheet 700,789 €
- RED ONE Pharma Retail sale of pharmaceutical products Brussels · balance sheet €1.19m
- Debrafo Business and other management consultancy activities Oostkamp · balance sheet €1.24m
- Slide Management Business and other management consultancy activities Faimes · balance sheet €1.04m
- Jedafra Business and other management consultancy activities Namur · balance sheet €1.29m
- ATC Consult Business and other management consultancy activities Woluwe-Saint-Pierre · balance sheet €1.67m
- Construct Support Business and other management consultancy activities Wetteren · balance sheet €1.50m
- VJC Partners Business and other management consultancy activities Dinant · balance sheet €1.93m
Frequently asked questions about Ardal Pharma
What is the revenue of Ardal Pharma?
Ardal Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Ardal Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0843540209 for Ardal Pharma, if the company is VAT-registered. Its company number (CBE) is 0843.540.209.
Where is the registered office of Ardal Pharma?
According to the CBE register, the registered office of Ardal Pharma is in 1090 Jette.
What is the equity of Ardal Pharma?
At the close of the 2025 financial year, the equity of Ardal Pharma amounts to 788,921 €, a solvency of 64.8% of total assets.
Who manages Ardal Pharma?
The register lists 2 active mandates at Ardal Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Ardal Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →